19th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium
All presentations are followed by Q&A with the speaker
7:30 am Continental Breakfast and Exhibits
8:00 Welcome and Introductions| James T. Willerson, MD
8:15 Update on PCSK9 Inhibitors in Treating Elevated LDL| Vijay Nambi, MD, PhD
8:45 Discussion
9:00 Advances with TAVR: Should it Replace Surgery for most Patients with Valvular Aortic Stenosis? | R. David Fish, MD
9:30 Discussion
9:45 Catheter Based Repairs of the Mitral Valve: What is the Best Approach| Guilherme V. Silva, MD
10:15 Discussion
10:30 Break
10:45 Treating Ventricular Arrythmias by Catheter | Mohammad Saeed, MD
11:15 Discussion
Presentation of Ray C. Fish Award and Luncheon | Texas Heart Institute The Ansary Atrium
11:30- 1:15 Luncheon and Award Presentation
19th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium
1:30 pm Ray C. Fish Lecture
Molecules, Mechanisms and New Medicines for Hypertrophic Cardiomyopathy
Christine Edry Seidman, MD
Harvard Medical School
Departmentt of Genetics
Boston, Massachusetts
2:00 Treating Post-Menopausal Women with Hormonal Therapy: What is Safest and Best? | Stephanie Coulter, MD
2:30 Discussion
2:45 Will Treatment of Heart Failure Include Allegenic Mesenchymal Stem Cells with FDA Approval in 2020 and Beyond? | Emerson Perin, MD, PhD
3:15 Discussion
3:30 Advances in Treating Heart Failure by Stimulating Cardiogenesis Directly in Preclinical Models with Ischemic Injury and CHF | James F. Martin, MD, PhD
4:00 Discussion
4:15 The Role of Inhibitors of Glucose and Sodium Transport in the Treatment of Heart Failure | Darren K. McGuire, MD, M.H.Sc.
4:45 Discussion
5:00 Final Summary | James T. Willerson, MD